Spesolimab for a child with generalized pustular psoriasis accompanied epilepsy and hyperactivity
Spesolimab is effective in treating pediatric GPP patients, and it is potential to be a clinical treatment strategy for pediatric GPP in the future.
Authors
- Mei Yang (ORCID: https://orcid.org/0000-0002-6168-0084)
- Peng Li (ORCID: https://orcid.org/0000-0003-4496-8702)
- Yudan Wang (ORCID: https://orcid.org/0000-0001-8605-9609)
- Jie Qin (ORCID: https://orcid.org/0000-0002-4986-8113)
- Yanyan Feng (ORCID: https://orcid.org/0009-0003-3222-667X)
- Lan He (ORCID: https://orcid.org/0000-0001-6744-9812)
- Beichen Yang (ORCID: https://orcid.org/0000-0002-7632-1148)
Institutions
- Chengdu Second People's Hospital (CN)
Publication Details
- Journal
- Journal of Dermatological Treatment
- Published
- 2025-09-22
- DOI
- https://doi.org/10.1080/09546634.2025.2555210
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00